ALRN: Aileron Therapeutics, Inc. Stock

by  •  • Comments Off on ALRN: Aileron Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 81.30
Enterprise Value ($M) 155.40
Book Value ($M) 98.30
Book Value / Share 5.79
Price / Book 0.83
NCAV ($M) 10.55
NCAV / Share 0.62
Price / NCAV 7.70

Profitability (mra)
Return on Invested Capital (ROIC) -0.16
Return on Assets (ROA) -0.92
Return on Equity (ROE) -1.10

Liquidity (mrq)
Quick Ratio 4.17
Current Ratio 4.17

Balance Sheet (mrq) ($M)
Current Assets 18.27
Assets 106.01
Liabilities 7.71
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -15.35
Net Income -15.73
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -19.81
Cash from Investing 16.20
Cash from Financing 15.79

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
8 days ago 13D/A Satter Muneer A 4.90 -18.34
03-05 13G University Of Texas/texas Am Investment Managment Co 6.20
02-14 13G/A Biotechnology Value Fund L P 0.00 -100.00
02-05 13G/A Kapnick Scott 0.00
11-13 13G BIOS Fund I, LP 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-10-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-04-28 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2022 OR ☐

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-23 22,687 67,581 33.57
2024-04-22 21,633 109,622 19.73
2024-04-19 11,956 12,943 92.37
2024-04-18 593,296 293,787 201.95

(click for more detail)

Similar Companies
ALBT – Avalon GloboCare Corp. ALDX – Aldeyra Therapeutics, Inc.
ALGS – Aligos Therapeutics, Inc. ALZN – Alzamend Neuro, Inc.
ANEB – Anebulo Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io